Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jamie Kuzniar

Optometrist Bloomfield, MI Doctor of Optometry

NPI 1871943449 CMS profile 1411595

4114 W Maple Rd, Bloomfield, MI 48301

Open in the dashboard

General payments

$473,099

1,006 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jamie Kuzniar of Bloomfield, MI is reported in the CMS Open Payments database as having received $473,099 across 1,006 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $74,926 179
2024 General $70,785 156
2023 General $81,361 135
2022 General $74,275 162
2021 General $106,835 198
2020 General $34,676 79
2019 General $30,240 97

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jamie Kuzniar
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Jamie Kuzniar were reported at $74,926. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Jamie Kuzniar Optometrist median Middle half National median
2019 $30,240 $159 $67–$371 $163
2020 $34,676 $72 $29–$165 $114
2021 $106,835 $125 $46–$292 $132
2022 $74,275 $162 $66–$374 $149
2023 $81,361 $177 $72–$406 $160
2024 $70,785 $188 $77–$427 $164
2025 $74,926 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bausch & Lomb Americas Inc. $267,701 397 payments
  2. Alcon Vision LLC $139,821 298 payments
  3. Bausch & Lomb, a division of Bausch Health US, LLC $39,966 87 payments
  4. CooperVision Inc. $6,111 81 payments
  5. OCULUS, Inc. $5,092 6 payments
  6. Alcon Research LLC $4,200 1 payment
  7. Johnson & Johnson Vision Care, Inc. $3,601 40 payments
  8. Glaukos Corporation $3,461 10 payments
  9. Allergan Inc. $469 12 payments
  10. Sight Sciences, Inc. $365 7 payments
  11. Other $2,312 67 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $181,404 95 payments
  2. Consulting Fee $166,140 116 payments
  3. Travel and Lodging $65,949 312 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $31,188 40 payments
  5. Food and Beverage $19,895 432 payments
  6. Honoraria $5,000 5 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,500 5 payments
  8. Entertainment $22 1 payment
Products named General payments · program years 2019–2025
  1. ZENLENS $150,895 201 payments
  2. ZEN LENS $91,739 140 payments
  3. ILUX $35,464 41 payments
  4. Precision 1 $35,052 57 payments
  5. DAILIES $24,681 41 payments
  6. TOTAL30 $15,271 29 payments
  7. DAILIES TOTAL1 $12,927 25 payments
  8. ARISE $12,216 22 payments
  9. REVIVE $7,284 7 payments
  10. SOFLENS $5,934 4 payments
  11. Other $39,903 376 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$8,232

Medicare's payments for the services billed

Medicare patients

42

Average age 72

Services billed

108

29 women, 13 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 64%
Arthritis 52%
Ischemic heart disease 31%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XDEMVY
$102 — —
MIEBO
$10 — —
XIIDRA
$10 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

1,006 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record